Correlation Between MoonLake Immunotherapeuti and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MoonLake Immunotherapeuti and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MoonLake Immunotherapeuti and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MoonLake Immunotherapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on MoonLake Immunotherapeuti and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MoonLake Immunotherapeuti with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MoonLake Immunotherapeuti and Terns Pharmaceuticals.
Diversification Opportunities for MoonLake Immunotherapeuti and Terns Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between MoonLake and Terns is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding MoonLake Immunotherapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and MoonLake Immunotherapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MoonLake Immunotherapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of MoonLake Immunotherapeuti i.e., MoonLake Immunotherapeuti and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between MoonLake Immunotherapeuti and Terns Pharmaceuticals
Given the investment horizon of 90 days MoonLake Immunotherapeutics is expected to generate 0.92 times more return on investment than Terns Pharmaceuticals. However, MoonLake Immunotherapeutics is 1.09 times less risky than Terns Pharmaceuticals. It trades about 0.24 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest 4,620 in MoonLake Immunotherapeutics on August 25, 2024 and sell it today you would earn a total of 812.00 from holding MoonLake Immunotherapeutics or generate 17.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
MoonLake Immunotherapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| MoonLake Immunotherapeuti |
| Terns Pharmaceuticals |
MoonLake Immunotherapeuti and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MoonLake Immunotherapeuti and Terns Pharmaceuticals
The main advantage of trading using opposite MoonLake Immunotherapeuti and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MoonLake Immunotherapeuti position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.The idea behind MoonLake Immunotherapeutics and Terns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Akari Therapeutics PLC | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |